Leading Law Firm Bleichmar Fonti & Auld LLP announces an investigation of WideOpenWest, Inc.’s (NYSE: WOW) potential merger with DigitalBridge Investments, LLC; Contact the Firm for More Details
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- If you invested in WideOpenWest you are encouraged to obtain additional information by contacting Ross Shikowitz at ross@bfalaw.com, https://www.bfalaw.com/cases/wideopenwest-inc-investigation, or calling us at 212-789-3619.
There is no cost to you.
Claim Details:
On May 3, 2024, WideOpenWest, Inc. announced receipt of an unsolicited non-binding preliminary proposal from DigitalBridge Investments, LLC and various Crestview entities to purchase all of the outstanding shares of WOW! that Crestview does not currently own for $4.80 per share in cash. BFA Law is currently investigating the proposal to determine whether WideOpenWest, Inc.’s board of directors is conflicted, engaging in an unfair process, and agreeing to an unfair amount to be paid to shareholders.
Go to https://www.bfalaw.com/cases/wideopenwest-inc-investigation for more details.
Next Steps:
If you currently own shares of WideOpenWest, Inc. you may have legal options.
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Contact:
Ross Shikowitz
ross@bfalaw.com
212-789-2303
Visit https://www.bfalaw.com/cases/wideopenwest-inc-investigation for more information.
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder derivative litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Attorney advertising. Past results do not guarantee future outcomes.
![](https://ml.globenewswire.com/media/Nzg0M2QzYTgtZmEwOS00NzAwLWEzZTQtYjkzYmM3OWJhYTIwLTEzMDI1NDU=/tiny/Bleichmar-Fonti-Auld.png)
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software